Li Jiyuan, Yuan Wenjia, Gao Chen, Liu Lei, Song Lei, Cao Wei, Zhu Xuejing, Han Yachun, Liang Ruobing, Lan Gongbin, Yu Shaojie, Wang Yu, Tan Liang, Dai Helong, Xie Xubiao, Peng Longkai, Peng Fenghua
Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Department of Medical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Front Cell Infect Microbiol. 2025 Aug 11;15:1563962. doi: 10.3389/fcimb.2025.1563962. eCollection 2025.
Prompt identification and management of donor-derived infections post-kidney transplantation are critical. This study aims to assess the effectiveness of metagenomic next-generation sequencing (mNGS) in detecting pathogens within donor organ preservation fluids and recipient wound drainage fluids, with a comparison made against conventional culture methods.
This study involved 141 kidney transplant patients (May 1st, 2020 to Jan 31st, 2024). Donor organ preservation fluids and recipient wound drainage fluids were collected and analyzed by mNGS and conventional culture. Pathogen detection differences between mNGS and culture were evaluated. The antibiotic adjustment and infectious complications of the recipients were recorded.
For organ preservation fluids, the positive rate of convention culture were lower than that of mNGS (24.8% (35/141) vs 47.5% (67/141), p<0.05). For recipient wound drainage fluids, the positivity rate of convention culture were lower than that of mNGS (2.1% (3/141) vs 27.0% (38/141), p<0.05). Compared to traditional culture-based methods, mNGS demonstrated a significantly higher positive detection rate for the combination of ESKAPE pathogens and/or fungi (28.4% (40/141) vs 16.3% (23/141) < 0.05). Of the pathogens detected through convention culture, mNGS was capable of detecting 79.2% (19/24) of combinations comprising Enterobacteriaceae and non-fermenting bacteria, yet it detected only 22.2% (2/9) of Gram-positive bacteria, and 55.6% (5/9) of fungi. Certain clinically atypical pathogens, mainly , , and parasites, can solely be detected via mNGS. The rehospitalization rate due to infections was 13.5% (19/141), while the donor-derived infection rate amounted to 2.8% (4/141). Guided by mNGS and bacterial culture results, adjustments were made to antibiotic administration, with no severe vascular complications arising.
By employing mNGS to analyze drainage fluids and organ preservation fluids, highly pathogenic and atypical pathogenic microorganisms can be rapidly identified with high throughput. While limitations exist in detecting fungi and Gram-positive bacteria, mNGS are need to be jointly applied with conventional culture under current conditions.
肾移植后及时识别和管理供体来源感染至关重要。本研究旨在评估宏基因组下一代测序(mNGS)在检测供体器官保存液和受体伤口引流液中病原体的有效性,并与传统培养方法进行比较。
本研究纳入141例肾移植患者(2020年5月1日至2024年1月31日)。收集供体器官保存液和受体伤口引流液,采用mNGS和传统培养方法进行分析。评估mNGS与培养法在病原体检测上的差异。记录受体的抗生素调整情况和感染并发症。
对于器官保存液,传统培养的阳性率低于mNGS(24.8%(35/141)对47.5%(67/141),p<0.05)。对于受体伤口引流液,传统培养的阳性率低于mNGS(2.1%(3/141)对27.0%(38/141),p<0.05)。与传统培养方法相比,mNGS对ESKAPE病原体和/或真菌组合的阳性检出率显著更高(28.4%(40/141)对16.3%(23/141),<0.05)。在通过传统培养检测出的病原体中,mNGS能够检测出79.2%(19/24)的肠杆菌科和非发酵菌组合,但仅检测出22.2%(2/9)的革兰氏阳性菌和55.6%(5/9)的真菌。某些临床非典型病原体,主要是 、 和寄生虫,只能通过mNGS检测到。因感染导致的再住院率为13.5%(19/141),而供体来源感染率为2.8%(4/141)。根据mNGS和细菌培养结果指导调整抗生素使用,未出现严重血管并发症。
通过采用mNGS分析引流液和器官保存液,可高通量快速鉴定高致病性和非典型致病微生物。虽然在检测真菌和革兰氏阳性菌方面存在局限性,但在当前条件下mNGS仍需与传统培养联合应用。